1-3 of 3
Oliver Schnell
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

MGMT Promoter Methylation Is a Strong Prognostic Biomarker for Benefit from Dose-Intensified Temozolomide Rechallenge in Progressive Glioblastoma: The DIRECTOR Trial

Michael Weller, Ghazaleh Tabatabai, Bärbel Kästner, Jörg Felsberg, Joachim P. Steinbach, Antje Wick, Oliver Schnell, Peter Hau, Ulrich Herrlinger, Michael C. Sabel, Hans-Georg Wirsching, Ralf Ketter, Oliver Bähr, Michael Platten, Jörg C. Tonn, Uwe Schlegel, Christine Marosi, Roland Goldbrunner, Roger Stupp, Krisztian Homicsko, Josef Pichler, Guido Nikkhah, Jürgen Meixensberger, Peter Vajkoczy, Spyros Kollias, Johannes Hüsing, Guido Reifenberger, Wolfgang Wick
Journal: Clinical Cancer Research
Clin Cancer Res (2015) 21 (9): 2057–2064.
https://doi.org/10.1158/1078-0432.CCR-14-2737
Published: 30 April 2015
View article titled, <em>MGMT</em> Promoter Methylation Is a Strong Prognostic Biomarker for Benefit from Dose-Intensified Temozolomide Rechallenge in Progressive Glioblastoma: The DIRECTOR Trial
Open the PDF for <em>MGMT</em> Promoter Methylation Is a Strong Prognostic Biomarker for Benefit from Dose-Intensified Temozolomide Rechallenge in Progressive Glioblastoma: The DIRECTOR Trial in another window
Includes: Supplementary data
Journal Articles

Molecular Markers in Low-Grade Gliomas: Predictive or Prognostic?

Christian Hartmann, Bettina Hentschel, Marcos Tatagiba, Johannes Schramm, Oliver Schnell, Clemens Seidel, Robert Stein, Guido Reifenberger, Torsten Pietsch, Andreas von Deimling, Markus Loeffler, Michael Weller
Journal: Clinical Cancer Research
Clin Cancer Res (2011) 17 (13): 4588–4599.
https://doi.org/10.1158/1078-0432.CCR-10-3194
Published: 05 July 2011
View article titled, Molecular Markers in Low-Grade Gliomas: Predictive or Prognostic?
Open the PDF for Molecular Markers in Low-Grade Gliomas: Predictive or Prognostic? in another window
Includes: Supplementary data
Journal Articles

Positron Emission Tomography Using [18F]Galacto-RGD Identifies the Level of Integrin αvβ3 Expression in Man

Ambros J. Beer, Roland Haubner, Mario Sarbia, Michael Goebel, Stephan Luderschmidt, Anca Ligia Grosu, Oliver Schnell, Markus Niemeyer, Horst Kessler, Hans-Jürgen Wester, Wolfgang A. Weber, Markus Schwaiger
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (13): 3942–3949.
https://doi.org/10.1158/1078-0432.CCR-06-0266
Published: 03 July 2006
View article titled, Positron Emission Tomography Using [<sup>18</sup>F]Galacto-RGD Identifies the Level of Integrin α<sub>v</sub>β<sub>3</sub> Expression in Man
Open the PDF for Positron Emission Tomography Using [<sup>18</sup>F]Galacto-RGD Identifies the Level of Integrin α<sub>v</sub>β<sub>3</sub> Expression in Man in another window